RBF Capital’s Compugen CGEN Stock Holding History

RBF Capital’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-13,700	Closed	-$30K	–	398
2018 Q4	$30K	Buy	+13,700	New	+$43.4K	﹤0.01%	400

Other funds holding CGEN

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return

Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return

Benjamin F. Edwards & Company St. Louis, Missouri $5.69B AUM 15.37% 1-Year Est. Return

Matrix Asset Advisors White Plains, New York $1.23B AUM 26.4% 1-Year Est. Return

RBF Capital's CGEN Position: Q1 2019 in Review

RBF Capital sold out of Compugen (CGEN) in Q1 2019, closing a stake of 13,700 shares — an estimated $30K sold.

RBF Capital first reported a position in CGEN in Q4 2018 and held it in 1 quarter. The position peaked at $30K in Q4 2018. 42 funds tracked by Wall St. Rank hold CGEN as of Q1 2019.

RBF Capital reported no remaining Compugen position as of Q1 2019 after selling out during the quarter.
RBF Capital sold 13,700 Compugen shares in Q1 2019, an estimated $30K.
RBF Capital first reported a position in Compugen in Q4 2018 and held it in 1 quarter.
RBF Capital's Compugen position peaked at $30K in Q4 2018.
42 funds tracked by Wall St. Rank held Compugen as of Q1 2019.

Based on RBF Capital's 13F filing for Q1 2019, filed 15 May 2019.